Self-Assessment: Immune Mediated Peripheral Neuropathies | Paradigm Clashes: Debate & Exploration in Choosing Traditional vs Novel Immunotherapeutics for MG

From 2024 Annual Meeting session content.

Course Description

Immune Mediated Peripheral Neuropathies
Discuss immune mediated peripheral neuropathies; asses how to suspect immune mediated peripheral neuropathies clinically and electrodiagnostically; and determine how to confirm the diagnosis and discuss treatment approaches.

Divyanshu Dubey, MBBS | Shruti Raja, MD | Rocio Vazquez Do Campo, MD

Paradigm Clashes: Debate & Exploration in Choosing Traditional vs Novel Immunotherapeutics for MG
Discuss advantages and pitfalls of traditional immunotherapies for MG such as corticosteroid, corticosteroid sparing agents, and thymectomy; describe advantages and pitfalls of novel immunotherapies such as B cell depleting agents, complement and FcRn inhibitors; and apply an individualized and cost-effective approach in managing patients.

Benjamin Claytor, MD | Neelam Goyal, MD | Michael K. Hehir, MD | Yuebing Li, MD, PhD | Amanda C. Guidon, MD

Objectives:
1. Asses how to suspect immune mediated peripheral neuropathies clinically and electrodiagnostically
2. Discuss advantages and pitfalls of traditional immunotherapies for MG such as corticosteroid, corticosteroid sparing agents, and thymectomy; describe advantages and pitfalls of novel immunotherapies such as B cell depleting agents, complement and FcRn inhibitors.

To claim self-assessment (SA) credit, you must watch the session recordings and answer a post-test. You must get above a 70% on the post-test survey to claim credit.

The American Board of Psychiatry and Neurology (ABPN) and the American Board of Physical Medicine and Rehabilitation (ABPMR) have reviewed and approved this product as part of a comprehensive lifelong learning program, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of maintenance of certification (MOC).

ACCREDITATION STATEMENT : The AANEM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION :
The AANEM designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits ^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE INFORMATION:
Dr. Divyanshu Dubey is a consultant for UCB, argenx, and Arialys Pharmaceuticals. Dr. Shruti Raja is a consultant for Regeneron, Signant Health (on MG outcome measures) Ocaro Pharmaceuticals, Ovid Therapeutics (for protocol development). Dr. Neelam Goyal is a consultant and on the advisory board for argenx, UCB, Alexion and Janssen, as well as receives grant support from argenx. Dr. Michael Hehir is a consultant for argenx, Alexion, UCB and Janssen. Dr. Yuebing Li is consultant for argenx, Alexion, Immunovant and UCB as well as receives grant support from argenx. Dr. Amanda Guidon is on the advisory board for Alexion, UCB and argenx. The full disclosure guide for all session planners can be found here. All conflicts of interest have been resolved in accordance with ACCME Standards for commercial support and ineligible companies.

Summary


Availability:	On-Demand
	Expires on Oct 14, 2027


Cost:	Member: $50.00 Non-Member: $75.00


Credit Offered:	3 SA CME Credits 3 CEU Credits